Advertisement

Topics

Takeda and Shire Receive Major Acquisition Clearance

18:30 EST 20 Nov 2018 | Investing News Network

The European Union has given the acquisition conditional clearance. Conditions pertain to potential overlap between the companies' inflammatory bowel disease products.

The post Takeda and Shire Receive Major Acquisition Clearance appeared first on Investing News Network.

Original Article: Takeda and Shire Receive Major Acquisition Clearance

NEXT ARTICLE

More From BioPortfolio on "Takeda and Shire Receive Major Acquisition Clearance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...